Cynthia Z Burton1, Ivy F Tso2, Ricardo E Carrión3, Tara Niendam4, Steven Adelsheim5, Andrea M Auther3, Barbara A Cornblatt3, Cameron S Carter4, Ryan Melton6, Tamara G Sale6, Stephan F Taylor2, William R McFarlane7. 1. University of Michigan, United States of America. Electronic address: czburton@umich.edu. 2. University of Michigan, United States of America. 3. Zucker Hillside Hospital, United States of America. 4. University of California, Davis, United States of America. 5. Stanford University, United States of America. 6. Oregon Health Sciences School of Public Health, United States of America. 7. Maine Medical Center Research Institute, United States of America; Tufts University School of Medicine, United States of America.
Abstract
BACKGROUND: As efforts intensify to intervene early among those at risk for psychosis, examination of the relationship between presenting psychopathology and long-term functional outcome may guide treatment decision-making and offer a means to prevent or reduce chronic disability. METHODS: Data were collected through the Early Detection and Intervention for the Prevention of Psychosis Program (EDIPPP), a multisite national trial testing the efficacy of an early intervention for youth at risk of developing psychosis. Participants were followed prospectively and completed comprehensive evaluations at 6, 12, and 24 months, including the Structured Interview for Prodromal Syndromes (SIPS) and the Global Social and Role Functioning Scales. The present analyses included 327 participants and examined the relationships between baseline symptoms and longitudinal global social and role functioning using a linear mixed modeling approach. RESULTS: Higher baseline negative symptoms and deteriorated thought process predicted worse social and role functioning in the follow-up period. The effect of negative symptoms on social functioning, however, was moderated by positive symptoms, and the relationship between positive symptoms and social functioning changed over time. Baseline positive symptoms, distress, and level of symptom severity were not predictors of either social or role functioning. CONCLUSIONS: Baseline negative symptoms and thought disorder appear to predict functional outcome for up to two years among adolescents and young adults at risk for psychosis. Developing effective interventions to target these symptoms may be critical to promote functional recovery among those experiencing attenuated symptoms or a first episode of psychosis.
BACKGROUND: As efforts intensify to intervene early among those at risk for psychosis, examination of the relationship between presenting psychopathology and long-term functional outcome may guide treatment decision-making and offer a means to prevent or reduce chronic disability. METHODS: Data were collected through the Early Detection and Intervention for the Prevention of Psychosis Program (EDIPPP), a multisite national trial testing the efficacy of an early intervention for youth at risk of developing psychosis. Participants were followed prospectively and completed comprehensive evaluations at 6, 12, and 24 months, including the Structured Interview for Prodromal Syndromes (SIPS) and the Global Social and Role Functioning Scales. The present analyses included 327 participants and examined the relationships between baseline symptoms and longitudinal global social and role functioning using a linear mixed modeling approach. RESULTS: Higher baseline negative symptoms and deteriorated thought process predicted worse social and role functioning in the follow-up period. The effect of negative symptoms on social functioning, however, was moderated by positive symptoms, and the relationship between positive symptoms and social functioning changed over time. Baseline positive symptoms, distress, and level of symptom severity were not predictors of either social or role functioning. CONCLUSIONS: Baseline negative symptoms and thought disorder appear to predict functional outcome for up to two years among adolescents and young adults at risk for psychosis. Developing effective interventions to target these symptoms may be critical to promote functional recovery among those experiencing attenuated symptoms or a first episode of psychosis.
Authors: Anthony O Ahmed; Gregory P Strauss; Robert W Buchanan; Brian Kirkpatrick; William T Carpenter Journal: Schizophr Bull Date: 2014-11-14 Impact factor: 9.306
Authors: Eric C Meyer; Ricardo E Carrión; Barbara A Cornblatt; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Thomas H McGlashan; Diana O Perkins; Ming T Tsuang; Elaine F Walker; Scott W Woods; Robert Heinssen; Larry J Seidman Journal: Schizophr Bull Date: 2014-02-18 Impact factor: 9.306
Authors: Tae Young Lee; Sung Nyun Kim; Christoph U Correll; Min Soo Byun; Euitae Kim; Joon Hwan Jang; Do-Hyung Kang; Je-Yeon Yun; Jun Soo Kwon Journal: Schizophr Res Date: 2014-05-09 Impact factor: 4.939
Authors: Ricardo E Carrión; Danielle McLaughlin; Terry E Goldberg; Andrea M Auther; Ruth H Olsen; Doreen M Olvet; Christoph U Correll; Barbara A Cornblatt Journal: JAMA Psychiatry Date: 2013-11 Impact factor: 21.596
Authors: Anthony O Ahmed; Gregory P Strauss; Robert W Buchanan; Brian Kirkpatrick; William T Carpenter Journal: J Psychiatr Res Date: 2017-11-12 Impact factor: 4.791
Authors: Barnaby Nelson; Hok Pan Yuen; Stephen J Wood; Ashleigh Lin; Daniela Spiliotacopoulos; Annie Bruxner; Christina Broussard; Magenta Simmons; Debra L Foley; Warrick J Brewer; Shona M Francey; G Paul Amminger; Andrew Thompson; Patrick D McGorry; Alison R Yung Journal: JAMA Psychiatry Date: 2013-08 Impact factor: 21.596
Authors: Barbara A Cornblatt; Andrea M Auther; Tara Niendam; Christopher W Smith; Jamie Zinberg; Carrie E Bearden; Tyrone D Cannon Journal: Schizophr Bull Date: 2007-04-17 Impact factor: 9.306
Authors: Tyrone D Cannon; Kristin Cadenhead; Barbara Cornblatt; Scott W Woods; Jean Addington; Elaine Walker; Larry J Seidman; Diana Perkins; Ming Tsuang; Thomas McGlashan; Robert Heinssen Journal: Arch Gen Psychiatry Date: 2008-01
Authors: Tim Ziermans; Sanne de Wit; Patricia Schothorst; Mirjam Sprong; Herman van Engeland; René Kahn; Sarah Durston Journal: PLoS One Date: 2014-04-04 Impact factor: 3.240
Authors: Jerome H Taylor; Scott Appel; Matthew Eli; Aaron Alexander-Bloch; Lawrence Maayan; Raquel E Gur; Michael H Bloch Journal: J Child Adolesc Psychopharmacol Date: 2020-07-01 Impact factor: 2.576
Authors: Isabell Paetzold; Karlijn S F M Hermans; Anita Schick; Barnaby Nelson; Eva Velthorst; Frederike Schirmbeck; Jim van Os; Craig Morgan; Mark van der Gaag; Lieuwe de Haan; Lucia Valmaggia; Philip McGuire; Matthew Kempton; Inez Myin-Germeys; Ulrich Reininghaus Journal: JMIR Ment Health Date: 2021-11-19